---
title: Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive
  immune dysregulation and limited CAR-T expansion
date: '2023-09-22'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37738350/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230923180948&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: Prolonged cytopenias after chimeric antigen receptor (CAR) T cell therapy
  are a significant clinical problem and the underlying pathophysiology remains poorly
  understood. Here, we investigated how (CAR) T cell expansion dynamics and serum
  proteomics affect neutrophil recovery phenotypes after CD19-directed CAR T cell
  therapy. Survival favored patients with "intermittent" neutrophil recovery (e.g.,
  recurrent neutrophil dips) compared to either "quick" or "aplastic" recovery. While
  ...
disable_comments: true
---
Prolonged cytopenias after chimeric antigen receptor (CAR) T cell therapy are a significant clinical problem and the underlying pathophysiology remains poorly understood. Here, we investigated how (CAR) T cell expansion dynamics and serum proteomics affect neutrophil recovery phenotypes after CD19-directed CAR T cell therapy. Survival favored patients with "intermittent" neutrophil recovery (e.g., recurrent neutrophil dips) compared to either "quick" or "aplastic" recovery. While ...